✦ LIBER ✦
Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma
✍ Scribed by Mato, Anthony; Feldman, Tatyana; Zielonka, Tania; Singavi, Arun; Gadaletta, Gabriella; Waksmundzki, Kathryn; Bhattacharyya, Pritish; Chow, Kar Fai; Yang, Xiao; Panush, David; Agress, Harry; Rosario, Maria; Howlett, Christina; Pecora, Andrew; Goy, Andre
- Book ID
- 124155216
- Publisher
- Informa plc
- Year
- 2013
- Tongue
- English
- Weight
- 321 KB
- Volume
- 54
- Category
- Article
- ISSN
- 1042-8194
No coin nor oath required. For personal study only.